ストックスクリーナーアプリを入手
34.93
6.04%
1.99
前日終値:
$32.94
開ける：
$33.3
24時間の取引高:
809.61K
Relative Volume:
2.60
時価総額：
$1.12B
収益：
$566.77M
当期純損益:
$48.16M
株価収益率:
29.35
EPS:
1.19
ネットキャッシュフロー:
$274.29M
1週間 パフォーマンス:
+16.16%
1か月 パフォーマンス:
+10.64%
6か月 パフォーマンス:
+13.34%
1年 パフォーマンス:
-1.10%
1日の値動き範囲:
$33.28
$34.99
1週間の範囲:
$29.70
$34.99
52週間の値動き範囲:
$23.23
$42.29
Collegium Pharmaceutical Inc Stock (COLL) Company Profile
名前
Collegium Pharmaceutical Inc
セクター
電話
781-713-3699
住所
100 TECHNOLOGY CENTER DRIVE, STOUGHTON, MA
COLL を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
COLL
Collegium Pharmaceutical Inc
|
34.93 | 956.23M | 566.77M | 48.16M | 274.29M | 1.19 |
|
ZTS
Zoetis Inc
|
147.35 | 64.93B | 9.39B | 2.61B | 2.22B | 5.81 |
|
TAK
Takeda Pharmaceutical Co Adr
|
14.44 | 45.07B | 29.98B | 958.27M | 5.31B | 0.2964 |
|
HLN
Haleon Plc Adr
|
9.54 | 41.53B | 14.35B | 1.85B | 0 | 0.4023 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
16.37 | 18.37B | 16.54B | -1.64B | 749.00M | -1.45 |
|
UTHR
United Therapeutics Corp
|
301.50 | 13.68B | 2.99B | 1.21B | 1.13B | 25.06 |
Collegium Pharmaceutical Inc Stock (COLL) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-01-10 | アップグレード | Needham | Hold → Buy |
| 2024-07-30 | アップグレード | H.C. Wainwright | Neutral → Buy |
| 2024-06-07 | アップグレード | Jefferies | Hold → Buy |
| 2024-05-10 | ダウングレード | Needham | Buy → Hold |
| 2024-05-10 | ダウングレード | Piper Sandler | Overweight → Neutral |
| 2024-01-04 | ダウングレード | Jefferies | Buy → Hold |
| 2023-08-25 | 繰り返されました | Needham | Buy |
| 2023-05-02 | 再開されました | Jefferies | Buy |
| 2022-08-08 | ダウングレード | H.C. Wainwright | Buy → Neutral |
| 2022-02-15 | アップグレード | Cantor Fitzgerald | Neutral → Overweight |
| 2021-08-06 | ダウングレード | Cantor Fitzgerald | Overweight → Neutral |
| 2021-01-11 | 繰り返されました | H.C. Wainwright | Buy |
| 2020-07-14 | 開始されました | BWS Financial | Sell |
| 2020-05-27 | 開始されました | Guggenheim | Neutral |
| 2020-02-19 | 再開されました | Jefferies | Buy |
| 2019-10-30 | 繰り返されました | Needham | Buy |
| 2019-05-03 | 再開されました | H.C. Wainwright | Buy |
| 2019-04-12 | 再開されました | Janney | Buy |
| 2019-03-20 | 開始されました | SunTrust | Hold |
| 2019-01-16 | 繰り返されました | Needham | Buy |
| 2018-03-08 | 繰り返されました | H.C. Wainwright | Buy |
| 2018-02-07 | 繰り返されました | Needham | Buy |
| 2017-12-05 | 繰り返されました | Needham | Buy |
| 2017-09-11 | 開始されました | H.C. Wainwright | Buy |
| 2017-05-11 | 繰り返されました | Needham | Buy |
| 2016-09-13 | 開始されました | Gabelli & Co | Buy |
| 2015-06-01 | 開始されました | Jefferies | Buy |
| 2015-06-01 | 開始されました | Needham | Buy |
| 2015-06-01 | 開始されました | Piper Jaffray | Overweight |
すべてを表示
Collegium Pharmaceutical Inc (COLL) 最新ニュース
Collegium Pharmaceutical (COLL) Is Up 16.2% After Raising 2025 Revenue Guidance on Strong Q2 Results - simplywall.st
Collegium Pharmaceutical's Q2 2025: Key Contradictions on Jornay PM Sales Estimates and Pain Portfolio Competition - AInvest
Collegium Pharmaceutical (NASDAQ:COLL) Upgraded by Wall Street Zen to Strong-Buy Rating - MarketBeat
Collegium Pharmaceutical Reports Record Q2 2025 Revenue, Raises Outlook and Initiates $150M Share Repurchase Program - AInvest
Why Collegium Pharmaceutical (COLL) Rose 10.3% After Raising 2025 Revenue Guidance Despite Lower Earnings - simplywall.st
Collegium Pharmaceutical, Inc. (NASDAQ:COLL) Q2 2025 Earnings Call Transcript - Insider Monkey
Collegium Pharmaceutical: Q2 Earnings Snapshot - Greenwich Time
Collegium Pharmaceutical Reports Strong Q2 2025 Results - TipRanks
Collegium Pharmaceuticals Reports Strong Earnings and Growth - TipRanks
Collegium Pharmaceutical’s Strong Financial Performance and Strategic Growth Initiatives Justify Buy Rating - TipRanks
Truist Securities raises Collegium Pharmaceutical stock price target to $45 By Investing.com - Investing.com UK
Collegium Pharmaceutical (NASDAQ:COLL) Exceeds Q2 Expectations, Stock Jumps 10.2% - FinancialContent
Collegium raises 2025 revenue guidance to $760M as Jornay PM growth accelerates - MSN
Collegium Pharmaceutical Inc reports results for the quarter ended June 30Earnings Summary - TradingView
Collegium Pharmaceutical Q2 2025 slides: Revenue surges 29%, guidance raised - Investing.com
Collegium Pharmaceutical (COLL) Q2 Earnings and Revenues Surpass Estimates - sharewise.com
Compared to Estimates, Collegium Pharmaceutical (COLL) Q2 Earnings: A Look at Key Metrics - Yahoo Finance
SIXS ETF Implied Analyst Target Price: $58.24 - AInvest
Collegium Pharmaceutical Reports Record Q2 2025 Revenue - TipRanks
Collegium Pharmaceutical earnings beat by $0.02, revenue topped estimates - Investing.com Canada
Earnings Flash (COLL) Collegium Pharmaceutical, Inc. Reports Q2 Revenue $188.0M, vs. FactSet Est of $180.9M - MarketScreener
Earnings Flash (COLL) Collegium Pharmaceutical, Inc. Posts Q2 Adjusted EPS $1.68 per Share, vs. FactSet Est of $1.62 - MarketScreener
Collegium Reports Second Quarter 2025 Financial Results; Raises 2025 Outlook - GlobeNewswire
Collegium Pharmaceutical Q2 Earnings: Revenue Expected to Grow 24.2% YoY - AInvest
Collegium Pharmaceutical (COLL) Q2 Earnings: What To Expect - Yahoo Finance
Collegium Pharmaceutical is helping individuals with ADHD - KOIN.com
Collegium Pharmaceuticals is helping those with ADHD - KOIN.com
Moving Average Crossover Confirms Uptrend in Collegium Pharmaceutical Inc.Breakout Momentum Picks With Protection Outlined - metal.it
Collegium Pharmaceutical Inc. Rebound Backed by Sentiment ShiftLow Risk High Return Opportunities Identified - metal.it
Real Time Chart Alerts Flash Bullish on Collegium Pharmaceutical Inc.Trade Ready Stock Watch for Short Term Published - metal.it
When is Collegium Pharmaceutical Inc. stock expected to show significant growthInvest smarter with comprehensive market analysis - Jammu Links News
Does Collegium Pharmaceutical Inc. stock perform well during market downturnsCapitalize on high-yield stocks early - Jammu Links News
Is Collegium Pharmaceutical Inc. stock overvalued or undervaluedGet insider insights into market trends - Jammu Links News
What is the risk reward ratio of investing in Collegium Pharmaceutical Inc. stockUnlock powerful stock screening for profits - Jammu Links News
What catalysts could drive Collegium Pharmaceutical Inc. stock higher in 2025Capitalize on market momentum for profits - Jammu Links News
What are Collegium Pharmaceutical Inc. company’s key revenue driversAccess powerful market insights for free - Jammu Links News
Is Collegium Pharmaceutical Inc. a good long term investmentAchieve consistent profits with proven methods - Jammu Links News
How does Collegium Pharmaceutical Inc. compare to its industry peersMaximize gains with professional stock picks - Jammu Links News
How many analysts rate Collegium Pharmaceutical Inc. as a “Buy”Invest in stocks with long-term growth potential - Jammu Links News
Collegium Pharmaceutical Inc. Stock Analysis and ForecastAchieve superior capital gains with smart trades - Jammu Links News
Collegium Pharmaceutical to report Q2 2025 financial results on August 7, 2025. - AInvest
What are the technical indicators suggesting about Collegium Pharmaceutical Inc.Real Time Tracker With High Returns - Jammu Links News
Back to School advice to help kids with ADHD Thrive| Talk of Alabama | 8.1.2025 - WBMA
Collegium Pharmaceutical Inc (COLL) 財務データ
収益
当期純利益
現金流量
EPS
0.43%
0.47%
大文字化:
|
ボリューム (24 時間):